688317.SH
之江生物
SSE · Healthcare · Biotechnology · CN
CNY 17.17
−2.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -95.04x
- PEG TTM
- —
- Price / book
- 1.00x
- Price / sales
- 27.21x
- Price / cash flow
- 52.52x
Enterprise value
- Enterprise value
- CNY 1.1B
- EV / sales
- 9.13x
- EV / EBITDA
- 60.95x
- EV / EBIT
- -19.18x
- Market cap
- CNY 3.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026